Clinical trial

A Pilot of Methylphenidate in Mild Cognitive Impairment and Dementia Participants.

NCT03811847

Study summary

ClinicalTrials.gov

A Pilot of Methylphenidate in Mild Cognitive Impairment and Dementia Participants.

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Methylphenidate Extended Release Oral Capsule Normalized identity: methylphenidate Extended Release Oral Capsule View linked drug · Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-11-01

PhasePHASE4

Conditions

Alzheimer Dementiaverified · MONDO: Alzheimer disease

Interventions

Methylphenidate Extended Release Oral CapsuleDRUG · verified · RxNorm: methylphenidate Extended Release Oral Capsule

PlaceboOTHER

Sponsors & collaborators

Massachusetts General Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03811847 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.